335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
CFO THOUGHT LEADER - Ein Podcast von The Future of Finance is Listening
Kategorien:
A brief summary of this episode
CFO THOUGHT LEADER - Ein Podcast von The Future of Finance is Listening
A brief summary of this episode
